Directory
>
Anna Protopapas
Anna Protopapas
Chairperson of the Board | Mersana Therapeutics
Cambridge, Massachusetts, United States
Anna Protopapas
Summary
Anna Protopapas is a seasoned executive with over two decades of leadership experience in the biopharmaceutical and biotechnology sectors. She served as the President and CEO of Mersana Therapeutics from 2015 until her retirement in 2023, during which she significantly advanced the company's platform and pipeline in antibody-drug conjugates. Her prior roles include President of Millennium Pharmaceuticals and Executive Vice President at Takeda Pharmaceuticals, where she played a pivotal role in global business development and strategic acquisitions. Anna is currently the Chairperson of the Board at Nuvalent, Inc. and has held board positions at several other pharmaceutical companies. She holds degrees from prestigious institutions including Princeton, MIT, and Stanford, highlighting her strong educational background in engineering and business. Residing in Cambridge, Massachusetts, Anna is also known for her philanthropic efforts and commitment to mentoring the next generation of leaders in the life sciences industry.
Anna Protopapas
Work Experience
Chairperson of the Board at
Nuvalent, Inc.
March 2022 - Present
Board Member at
Mersana Therapeutics
March 2015 - Present
President and CEO - Retired at
Mersana Therapeutics
March 2015 - September 2023
Board Member at
Novo Nordisk Inc.
January 2019 - June 2021
Board Member at
Bioverativ
January 2017 - January 2018
Board Member at
Takeda Pharmaceuticals America, Inc.
May 2015 - January 2017
Executive Vice President and Corporate Officer, Global Licensing and Business Development at
TAKEDA PHARMACEUTICALS SRL
October 2010 - October 2014
President at
Takeda Pharmaceuticals America, Inc.
April 2013 - October 2014
Senior Vice President, Corporate and Business Development at
Takeda Oncology
October 2003 - October 2010
Vice President Of Business Development at
Millennium Pharmaceuticals
September 1997 - October 2003
Anna Protopapas
Education
Massachusetts Institute of Technology, Master Of Science In Engineering
Princeton University, Bachelor Of Science In Engineering
The English School, Nicosia, Cyprus
Frequently Asked Questions about Anna Protopapas
What is Anna Protopapas email address?
Anna Protopapas's primary email address is ***********@mersana.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Anna Protopapas work for?
Anna Protopapas is a Chairperson of the Board at Mersana Therapeutics, a company specializing in Commercial physical research.
Where Anna Protopapas graduated from?
Anna Protopapas holds a degree in Chemical Engineering from Massachusetts Institute of Technology.
How can I directly contact Anna Protopapas?
To contact Anna Protopapas directly, you can use the email address ***********@mersana.com. Complete contact information is available upon registration with Muraena.
Is Anna Protopapas an immigrant?
Yes, Anna Protopapas is an immigrant and currently based in United States
Who is Anna Protopapas?
Anna Protopapas is a seasoned executive with over two decades of leadership experience in the biopharmaceutical and biotechnology sectors. She served as the President and CEO of Mersana Therapeutics from 2015 until her retirement in 2023, during which she significantly advanced the company's platform and pipeline in antibody-drug conjugates. Her prior roles include President of Millennium Pharmaceuticals and Executive Vice President at Takeda Pharmaceuticals, where she played a pivotal role in global business development and strategic acquisitions. Anna is currently the Chairperson of the Board at Nuvalent, Inc. and has held board positions at several other pharmaceutical companies. She holds degrees from prestigious institutions including Princeton, MIT, and Stanford, highlighting her strong educational background in engineering and business. Residing in Cambridge, Massachusetts, Anna is also known for her philanthropic efforts and commitment to mentoring the next generation of leaders in the life sciences industry.
Anna`s contact details
***********@mersana.com
***************@mpi.com
Colleagues
VP, Information, Technology and Risk
Executive Director - Business Development & Corporate Strategy
SVP, Chief Legal Officer
Executive Director, Supplier Quality Drug Substance
Vice President, Clinical Quality Assurance
Executive Director, Sterile Drug Products
Chief Manufacturing Officer
Chief Development Officer
Vice President of Quality, Manufacturing
Executive Director Clinical Operations